FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Flentje

Research Profile

Concepts & Ideas

Procedures

Disorders

Co-author Network

Publications

TOP 3
Susanne Hartmann; Astrid Katzer; Georg Krohne; Sebastian Kuger; Vladimir Sukhorukov; Eike Worschech; Heiko Zimmermann; Marlene Biehl; Michael Flentje; Nadine Günther; Cholpon S Djuzenova
Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines.
Sebastian Kuger; Paul Lutyj; Buelent Polat; Vladimir Sukhorukov; Michael Flentje; Dorothea Graus; Nadine Günther; Astrid Katzer; Rico Brendtke; Manik Chatterjee; Cholpon S Djuzenova
Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule.
Cholpon S Djuzenova; Ines Elsner; Michael Flentje; Astrid Katzer; Luitpold Distel; Eike Worschech; Buelent Polat
Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Flentje (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Susanne Hartmann; Astrid Katzer; Georg Krohne; Sebastian Kuger; Vladimir Sukhorukov; Eike Worschech; Heiko Zimmermann; Marlene Biehl; Michael Flentje; Nadine Günther; Cholpon S Djuzenova
Hsp90 inhibition by NVP-AUY922 and NVP-BEP800 decreases migration and invasion of irradiated normoxic and hypoxic tumor cell lines.
Cancer letters 2013;331(2):200-10.
2013: Sebastian Kuger; Paul Lutyj; Buelent Polat; Vladimir Sukhorukov; Michael Flentje; Dorothea Graus; Nadine Günther; Astrid Katzer; Rico Brendtke; Manik Chatterjee; Cholpon S Djuzenova
Radiosensitization of Glioblastoma Cell Lines by the Dual PI3K and mTOR Inhibitor NVP-BEZ235 Depends on Drug-Irradiation Schedule.
Translational oncology 2013;6(2):169-79.
2013: Cholpon S Djuzenova; Ines Elsner; Michael Flentje; Astrid Katzer; Luitpold Distel; Eike Worschech; Buelent Polat
Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci.
Radiation oncology (London, England) 2013;8():98.
2013: Frederick Mantel; Michael Flentje; Matthias Guckenberger
Stereotactic body radiation therapy in the re-irradiation situation--a review.
Radiation oncology (London, England) 2013;8():7.
2013: Buelent Polat; A Technau; Gisela Wohlleben; Cholpon S Djuzenova; Astrid Katzer; Michael Flentje
Influence of osteopontin silencing on survival and migration of lung cancer cells.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2013;189(1):62-7.
2013: Juergen Wilbert; Christian Hermann; Kurt Baier; Michael Flentje; Matthias Guckenberger
Accuracy of real-time couch tracking during 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, and volumetric modulated arc therapy for prostate cancer.
International journal of radiation oncology, biology, physics 2013;85(1):237-42.
2012: Birgitt van Oorschot; Michael Schuler; Alfred Simon; Michael Flentje
Advance directives: prevalence and attitudes of cancer patients receiving radiotherapy.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(11):2729-36.
2012: Natalia Niewidok; Buelent Polat; Sarah Schiessl; Lavinia Stingl; Vladimir Sukhorukov; Linda-Jacqueline Wack; Michael Flentje; Astrid Katzer; Cholpon S Djuzenova
Hsp90 Inhibitors NVP-AUY922 and NVP-BEP800 May Exert a Significant Radiosensitization on Tumor Cells along with a Cell Type-Specific Cytotoxicity.
Translational oncology 2012;5(5):356-69.
2012: Heribert Hänscheid; Michael Kreissl; Mario Löhr; Samuel Samnick; Reinhart A Sweeney; Andreas K Buck; Michael Flentje; Frederik A Verburg
PET SUV correlates with radionuclide uptake in peptide receptor therapy in meningioma.
European journal of nuclear medicine and molecular imaging 2012;39(8):1284-8.
2012: Peter Schmitt; Michael Flentje; Axel Haase; Peter M Jakob; Markus Kotas; Mark Griswold
T-one insensitive steady state imaging: a framework for purely T2-weighted TrueFISP.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2012;68(2):409-20.
2012: Harun M Said; Adrian Staab; Susanne Stein; Jelena Anacker; Michael Flentje; Matthias Guckenberger; Carsten Hagemann; Astrid Katzer; Buelent Polat; Dirk Vordermark
Inhibition of N-Myc down regulated gene 1 in in vitro cultured human glioblastoma cells.
World journal of clinical oncology 2012;3(7):104-10.
2012: H Hintzsche; Leo Pfreundner; Buelent Polat; V Schewe; Cholpon S Djuzenova; Michael Flentje; Helga Stopper
Micronucleus formation kinetics in buccal mucosa cells of head and neck cancer patients undergoing radiotherapy.
Toxicology letters 2012;212(1):33-7.
2012: Matthias Guckenberger; G Saur; Reinhart A Sweeney; Andreas Thalheimer; D Wehner; C-T Germer; Michael Flentje
Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(7):551-7.
2012: Feray Kockar; Rahsan Ilikci Sagkan; Yasemin Soysal; Dirk Vordermark; Hatice Yildrim; Jelena Anacker; Michael Flentje; Carsten Hagemann; Ahmed Ayad Hamza; Harun M Said
Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro.
World journal of clinical oncology 2012;3(6):82-91.
2012: L Stingl; Cholpon S Djuzenova; N Müller; N Niewidok; M Selle; Michael Flentje
Radiosensitizing effect of the novel Hsp90 inhibitor NVP-AUY922 in human tumour cell lines silenced for Hsp90α.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(6):507-15.
2012: Cholpon S Djuzenova; Christina Blassl; Nadine Günther; Astrid Katzer; Sebastian Kuger; Natalia Niewidok; Buelent Polat; Konstanze Roloff; Vladimir Sukhorukov; Michael Flentje
Hsp90 inhibitor NVP-AUY922 enhances radiation sensitivity of tumor cell lines under hypoxia.
Cancer biology & therapy 2012;13(6):425-34.
2012: Matthias Guckenberger; Maria Hawkins; Michael Flentje; Reinhart A Sweeney
Fractionated radiosurgery for painful spinal metastases: DOSIS - a phase II trial.
BMC cancer 2012;12():530.
2012: Matthias Guckenberger; Nikolaus Alexandrow; Michael Flentje
Radiotherapy alone for stage I-III low grade follicular lymphoma: long-term outcome and comparison of extended field and total nodal irradiation.
Radiation oncology (London, England) 2012;7():103.
2012: Michael C Kreissl; Michael Lassmann; Mario Löhr; Christoph Reiners; Samuel S Samnick; Markus Schiller; Andreas K Buck; Michael Flentje; Heribert Hänscheid; Frederik A Verburg; Reinhart A Sweeney
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma.
Radiation oncology (London, England) 2012;7():99.
2012: Reinhart A Sweeney; Michael Flentje; Vanessa Homann; Gerd Müller; Benedikt Seubert; Silke Stark; Matthias Guckenberger
Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors.
Radiation oncology (London, England) 2012;7():81.
2012: Michael Flentje; Hans Hoffmann; Rudolf M Huber
[Quality assurance].
Onkologie 2012;35 Suppl 3():14-6.
2012: Matthias Guckenberger; Johannes Roesch; Reinhart A Sweeney; Kurt Baier; Michael Flentje
Dosimetric consequences of translational and rotational errors in frame-less image-guided radiosurgery.
Radiation oncology (London, England) 2012;7():63.
2011: Matthias Guckenberger; Anne Richter; Juergen Wilbert; Michael Flentje; Mike Partridge
Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control.
International journal of radiation oncology, biology, physics 2011;81(4):e275-82.
2011: Anne Richter; Juergen Wilbert; Michael Flentje
Dosimetric evaluation of intrafractional tumor motion by means of a robot driven phantom.
Medical physics 2011;38(10):5280-9.
2011: Matthias Guckenberger; Mario Mayer; Reinhart A Sweeney; Giles H Vince; Mathias Buttmann; Michael Flentje
Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2011;187(9):548-54.
2011: Judit Boda-Heggemann; Michael Flentje; Frank Lohr; Frederik Wenz; Matthias Guckenberger
kV cone-beam CT-based IGRT: a clinical review.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2011;187(5):284-91.
2011: Florian Sterzing; Rita Engenhart-Cabillic; Michael Flentje; Jürgen Debus
Image-guided radiotherapy: a new dimension in radiation oncology.
Deutsches Ärzteblatt international 2011;108(16):274-80.
2011: Adrian Staab; Markus Fleischer; Juergen Loeffler; Harun M Said; Astrid Katzer; Christian Plathow; Herrmann Einsele; Michael Flentje; Dirk Vordermark
Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2011;187(4):252-9.
2011: Wolfram Machann; Meinrad Beer; Margret Breunig; Stefan Störk OR Stoerk; Christiane Angermann; Ines Seufert; Franz Schwab; Oliver Kölbl; Michael Flentje; Dirk Vordermark
Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin's disease.
International journal of radiation oncology, biology, physics 2011;79(4):1117-23.
2011: André O von Bueren; Monika Warmuth-Metz; Paul G Schlegel; Niels Soerensen; Juergen Krauss; Wolfgang Roggendorf; Torsten Pietsch; Wolfgang Feiden; Norbert Graf; Fabian Pohl; Michael Flentje; Joachim Kuehl; Stefan Rutkowski
Late complete remission of supratentorial primitive neuroectodermal tumor (CNS-PNET) after multiple relapses.
Pediatric blood & cancer 2011;56(3):503-5.
2011: Matthias Guckenberger; Juergen Wilbert; Anne Richter; Kurt Baier; Michael Flentje
Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.
International journal of radiation oncology, biology, physics 2011;79(3):901-8.
2011: Klaus Bratengeier; Mark Gainey; Michael Flentje
Fast IMRT by increasing the beam number and reducing the number of segments.
Radiation oncology (London, England) 2011;6():170.
2011: Klaus Bratengeier; Mark Gainey; Otto Sauer; Anne Richter; Michael Flentje
Fast intensity-modulated arc therapy based on 2-step beam segmentationa.
Medical physics 2011;38(1):151-65.
2010: Thomas Kuhnt; A Sandner; T Wendt; Rita Engenhart-Cabillic; G Lammering; Michael Flentje; Gerhard G Grabenbauer; A Schreiber; A Pirnasch; Jürgen Dunst
Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(11):2284-9.
2010: Matthias Guckenberger; Sami Ok; Buelent Polat; Reinhart A Sweeney; Michael Flentje
Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2010;186(10):535-43.
2010: Matthias Guckenberger; Kurt Baier; Buelent Polat; Anne Richter; Thomas Krieger; Juergen Wilbert; Gerd Mueller; Michael Flentje
Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;97(1):65-70.
2010: Anne Richter; Juergen Wilbert; Kurt Baier; Michael Flentje; Matthias Guckenberger
Feasibility study for markerless tracking of lung tumors in stereotactic body radiotherapy.
International journal of radiation oncology, biology, physics 2010;78(2):618-27.
2010: Marion Wobser; Daniela Göppner; Sabrina C Lang; Gabriele Beckmann; Michael Flentje; Selma Ugurel; Eva-B Bröcker; Jürgen C Becker
Durable complete remission of therapy-refractory, tumor-stage cutaneous T-cell lymphoma under radioimmunotherapy with electron beam irradiation and denileukin diftitox.
Archives of dermatology 2010;146(7):805-6.
2010: Philipp Mörchel; Gerd Melkus; Ala Yaromina; Daniel Zips; Michael Baumann; Peter M Jakob; Michael Flentje
Correlating quantitative MR measurements of standardized tumor lines with histological parameters and tumor control dose.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;96(1):123-30.
2010: Juergen Wilbert; Kurt Baier; Anne Richter; Christian Herrmann; Lei Ma; Michael Flentje; Matthias Guckenberger
Influence of continuous table motion on patient breathing patterns.
International journal of radiation oncology, biology, physics 2010;77(2):622-9.
2010: L Stingl; Thorsten Stühmer; Manik Chatterjee; Michael Rugaard Jensen; Michael Flentje; Cholpon S Djuzenova
Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction.
British journal of cancer 2010;102(11):1578-91.
2010: Harun M Said; Claudiu T Supuran; Carsten Hageman; Adrian Staab; Buelent Polat; Astrid Katzer; Andrea Scozzafava; Jelena Anacker; Michael Flentje; Dirk Vordermark
Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.
Current pharmaceutical design 2010;16(29):3288-99.
2010: Carsten Hagemann; Harun M Said; Michael Flentje; Klaus Roosen; Giles H Vince
Proteins involved in cell migration from glioblastoma neurospheres analyzed by overexpression and siRNA-mediated knock-down.
Methods in molecular biology (Clifton, N.J.) 2010;650():129-43.
2010: Juergen Wilbert; Matthias Guckenberger; Buelent Polat; Otto Sauer; Michael Vogele; Michael Flentje; Reinhart A Sweeney
Semi-robotic 6 degree of freedom positioning for intracranial high precision radiotherapy; first phantom and clinical results.
Radiation oncology (London, England) 2010;5():42.
2010: Rudolf M Huber; Astrid Borgmeier; Michael Flentje; Jochen Willner; Michael Schmidt; Christian Manegold; Peter Bramlage; Jürgen Debus
Concurrent chemoradiation therapy with docetaxel/cisplatin followed by docetaxel consolidation therapy in inoperable stage IIIA/B non-small-cell lung cancer: results of a phase I study.
Clinical lung cancer 2010;11(1):45-50.
2010: Matthias Guckenberger; Johanna Bachmann; Jörn Wulf; Gerd Mueller; Thomas Krieger; Kurt Baier; Anne Richter; Juergen Wilbert; Michael Flentje
Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;94(1):53-9.
2009: Klaus Bratengeier; Buelent Polat; Mark Gainey; Patricia Grewenig; Jürgen Meyer; Michael Flentje
Is ad-hoc plan adaptation based on 2-Step IMRT feasible?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;93(2):266-72.
2009: Matthias Guckenberger; Anne Richter; Thomas Krieger; Juergen Wilbert; Kurt Baier; Michael Flentje
Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;93(2):259-65.
2009: Matthias Guckenberger; Joachim Goebel; Juergen Wilbert; Kurt Baier; Anne Richter; Reinhart A Sweeney; Klaus Bratengeier; Michael Flentje
Clinical outcome of dose-escalated image-guided radiotherapy for spinal metastases.
International journal of radiation oncology, biology, physics 2009;75(3):828-35.
2009: Gerd Melkus; Philipp Mörchel; Volker C Behr; Markus Kotas; Michael Flentje; Peter M Jakob
Sensitive J-coupled metabolite mapping using Sel-MQC with selective multi-spin-echo readout.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2009;62(4):880-7.
2009: Harun M Said; Buelent Polat; Carsten Hagemann; Giles H Vince; Jelena Anacker; Ulrike K Mmerer; Michael Flentje; Dirk Vordermark
Egr-1 is not upregulated in response to hypoxic and oxygenation conditions in human glioblastoma in vitro.
Molecular medicine reports 2009;2(5):757-63.
2009: Andreas Dietz; Volker Rudat; Jens Dreyhaupt; Maria Pritsch; Florian Hoppe; Rudolf Hagen; Leo Pfreundner; Ursula Schröder; Hans Eckel; Markus Hess; M Schröder; Petra Schneider; Bünzel Jens; Hans P Zenner; Jochen A Werner; Rita Engenhardt-Cabillic; Bernhard Vanselow; Peter K Plinkert; Marcus Niewald; Thomas Kuhnt; Wilfried Budach; Michael Flentje
Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial).
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2009;266(8):1291-300.
2009: Cholpon S Djuzenova; Julia Krasnyanska; M Kiesel; Lavinia Stingl; Ulrich Zimmermann; Michael Flentje; Vladimir Sukhorukov
Intracellular delivery of 2-deoxy-D-glucose into tumor cells by long-term cultivation and through swelling-activated pathways: implications for radiation treatment.
Molecular medicine reports 2009;2(4):633-40.
2009: Anne Richter; Reinhard Sweeney; Kurt Baier; Michael Flentje; Matthias Guckenberger
Effect of breathing motion in radiotherapy of breast cancer: 4D dose calculation and motion tracking via EPID.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(7):425-30.
2009: Buelent Polat; Martin Fassnacht; Leo Pfreundner; Matthias Guckenberger; Klaus Bratengeier; Sarah Johanssen; Werner Kenn; Stefanie Hahner; Bruno Allolio; Michael Flentje
Radiotherapy in adrenocortical carcinoma.
Cancer 2009;115(13):2816-23.
2009: Matthias Guckenberger; Juergen Wilbert; Thomas Krieger; Anne Richter; Kurt Baier; Michael Flentje
Mid-ventilation concept for mobile pulmonary tumors: internal tumor trajectory versus selective reconstruction of four-dimensional computed tomography frames based on external breathing motion.
International journal of radiation oncology, biology, physics 2009;74(2):602-9.
2009: Matthias Guckenberger; Thomas Krieger; Anne Richter; Kurt Baier; Juergen Wilbert; Reinhart A Sweeney; Michael Flentje
Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;91(3):288-95.
2009: Dirk Vordermark; Michael Noe; Klaus Markert; Jörn Wulf; Gerd Müller; Klaus Bratengeier; Gabriele Beckmann; Fabian Baier; Matthias Guckenberger; Frank Schiefelbein; Georg Schön; Michael Flentje; Kurt Baier
Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;91(2):217-24.
2009: Matthias Guckenberger; Jörn Wulf; Gerd Mueller; Thomas Krieger; Kurt Baier; Manuela Gabor; Anne Richter; Juergen Wilbert; Michael Flentje
Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation.
International journal of radiation oncology, biology, physics 2009;74(1):47-54.
2009: Matthias Guckenberger; Kurt Baier; Anne Richter; Juergen Wilbert; Michael Flentje
Evolution of surface-based deformable image registration for adaptive radiotherapy of non-small cell lung cancer (NSCLC).
Radiation oncology (London, England) 2009;4():68.
2009: Matthias Guckenberger; Jörn Wulf; Andreas Thalheimer; Daniel Wehner; Arnulf Thiede; Gottfried Müller; Marco Sailer; Michael Flentje
Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy--long-term results.
Radiation oncology (London, England) 2009;4():67.
2009: Klaus Bratengeier; Markus Oechsner; Mark Gainey; Michael Flentje
Remarks on reporting and recording consistent with the ICRU reference dose.
Radiation oncology (London, England) 2009;4():44.
2009: Klaus Bratengeier; Jürgen Meyer; Franz Schwab; Dirk Vordermark; Michael Flentje
Steep dose gradients for simultaneous integrated boost IMRT.
Zeitschrift für medizinische Physik 2009;19(2):129-35.
2009: Jürgen Meyer; Anne Richter; Leo Pfreundner; Matthias Guckenberger; Thomas Krieger; Franz Schwab; Michael Flentje
An interlaced IMRT technique for elongated tumor volumes.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2009;34(2):170-8.
2009: Markus Kotas; Peter Schmitt; Peter M Jakob; Michael Flentje
Monitoring of tumor oxygenation changes in head-and-neck carcinoma patients breathing a hyperoxic hypercapnic gas mixture with a noninvasive MRI technique.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(1):19-26.
2009: Harun M Said; Buelent Polat; Carsten Hagemann; Jelena Anacker; Michael Flentje; Dirk Vordermark
Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in - vitro.
BMC research notes 2009;2():8.
2009: Carsten Hagemann; Jens Gloger; Jelena Anacker; Harun M Said; Stefanie Gerngras; Siglinde Kühnel; Christoph Meyer; Ulf Rüdiger Rapp; Ulrike Kämmerer; Dirk Vordermark; Michael Flentje; Klaus Roosen; Giles Hamilton Vince
RAF expression in human astrocytic tumors.
International journal of molecular medicine 2009;23(1):17-31.
2009: Harun M Said; Susanne Stein; Carsten Hagemann; Buelent Polat; Adrian Staab; Jelena Anacker; Beate Schoemig; Matthias Theobald; Michael Flentje; Dirk Vordermark
Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
Oncology reports 2009;21(1):237-46.
2008: Buelent Polat; Iris Guenther; Juergen Wilbert; Joachim Goebel; Reinhart A Sweeney; Michael Flentje; Matthias Guckenberger
Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(12):668-73.
2008: Johannes F T Arnold; Markus Kotas; Robert W Pyzalski; Eberhard D Pracht; Michael Flentje; Peter M Jakob
Potential of magnetization transfer MRI for target volume definition in patients with non-small-cell lung cancer.
Journal of magnetic resonance imaging : JMRI 2008;28(6):1417-24.
2008: Gerd Melkus; Philipp Mörchel; Volker C Behr; Markus Kotas; Michael Flentje; Peter M Jakob
Short-echo spectroscopic imaging combined with lactate editing in a single scan.
NMR in biomedicine 2008;21(10):1076-86.
2008: Juergen Wilbert; Jürgen Meyer; Kurt Baier; Matthias Guckenberger; Christian Herrmann; Robin Hess; Christian Janka; Lei Ma; Torben Mersebach; Anne Richter; Michael Roth; Klaus Schilling; Michael Flentje
Tumor tracking and motion compensation with an adaptive tumor tracking system (ATTS): system description and prototype testing.
Medical physics 2008;35(9):3911-21.
2008: Harun M Said; Buelent Polat; Adrian Staab; Carsten Hagemann; Susanne Stein; Michael Flentje; Mathias Theobald; Astrid Katzer; Dirk Vordermark
Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro.
Oncology reports 2008;20(2):413-9.
2008: Veronika Ludwig; Franz Schwab; Matthias Guckenberger; Thomas Krieger; Michael Flentje
Comparison of wedge versus segmented techniques in whole breast irradiation: effects on dose exposure outside the treatment volume.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(6):307-12.
2008: Matthias Guckenberger; Reinhart A Sweeney; Juergen Wilbert; Thomas Krieger; Anne Richter; Kurt Baier; Gerd Mueller; Otto Sauer; Michael Flentje
Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography.
International journal of radiation oncology, biology, physics 2008;71(1):297-304.
2008: Jürgen Richter; Kurt Baier; Michael Flentje
Comparison of 60cobalt and 192iridium sources in high dose rate afterloading brachytherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(4):187-92.
2008: Andreas Dietz; U Keilholz; J Werner; R Hagen; Michael Flentje; Heinrich Iro
[Current role for induction chemotherapy in head and neck tumors].
Laryngo- rhino- otologie 2008;87(4):237-43; discussion 244.
2008: Cholpon S Djuzenova; Teresa Güttler; Sabrina Berger; Astrid Katzer; Michael Flentje
Differential response of human glioblastoma cell lines to combined camptothecin and ionizing radiation treatment.
Cancer biology & therapy 2008;7(3):364-73.
2008: Anne Richter; Qiaoqiao Hu; Doreen Steglich; Kurt Baier; Jürgen Wilbert; Matthias Guckenberger; Michael Flentje
Investigation of the usability of conebeam CT data sets for dose calculation.
Radiation oncology (London, England) 2008;3():42.
2008: Anne Richter; Kurt Baier; Juergen Meyer; Juergen Wilbert; Thomas Krieger; Michael Flentje; Matthias Guckenberger
Influence of increased target dose inhomogeneity on margins for breathing motion compensation in conformal stereotactic body radiotherapy.
BMC medical physics 2008;8():5.
2008: Claus Rödel; Thomas Höhler; Rolf Sauer; René Siewczynski; Michael Flentje; Volker Budach; Peter M Schlag
[Multimodality treatment for colorectal cancer].
Onkologie 2008;31 Suppl 5():24-8.
2008: Klaus Bratengeier; Jürgen Meyer; Michael Flentje
Pre-segmented 2-Step IMRT with subsequent direct machine parameter optimisation - a planning study.
Radiation oncology (London, England) 2008;3():38.
2008: Matthias Guckenberger; Kurt Baier; Anne Richter; Dirk Vordermark; Michael Flentje
Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?
Radiation oncology (London, England) 2008;3():3.
2008: André Fischer; Eberhard D Pracht; Johannes F T Arnold; Markus Kotas; Michael Flentje; Peter M Jakob
Assessment of pulmonary perfusion in a single shot using SEEPAGE.
Journal of magnetic resonance imaging : JMRI 2008;27(1):63-70.
2007: Matthias Guckenberger; Katrin Heilman; Jörn Wulf; Gerd Mueller; Gabriele Beckmann; Michael Flentje
Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;85(3):435-42.
2007: Dirk Vordermark; Andrea Lackenbauer; Jörn Wulf; Matthias Guckenberger; Michael Flentje
Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
Oncology reports 2007;18(5):1335-9.
2007: Matthias Guckenberger; Markus Weininger; Juergen Wilbert; Anne Richter; Kurt Baier; Thomas Krieger; Buelent Polat; Michael Flentje
Influence of retrospective sorting on image quality in respiratory correlated computed tomography.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;85(2):223-31.
2007: Buelent Polat; Juergen Wilbert; Kurt Baier; Michael Flentje; Matthias Guckenberger
Nonrigid patient setup errors in the head-and-neck region.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(9):506-11.
2007: Klaus Bratengeier; Matthias Guckenberger; Jürgen Meyer; Gerd Müller; Leo Pfreundner; Franz Schwab; Michael Flentje
A comparison between 2-Step IMRT and conventional IMRT planning.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;84(3):298-306.
2007: Matthias Guckenberger; Kurt Baier; Iris Guenther; Anne Richter; Juergen Wilbert; Otto Sauer; Dirk Vordermark; Michael Flentje
Reliability of the bony anatomy in image-guided stereotactic radiotherapy of brain metastases.
International journal of radiation oncology, biology, physics 2007;69(1):294-301.
2007: Matthias Guckenberger; Juergen Wilbert; Thomas Krieger; Anne Richter; Kurt Baier; Juergen Meyer; Michael Flentje
Four-dimensional treatment planning for stereotactic body radiotherapy.
International journal of radiation oncology, biology, physics 2007;69(1):276-85.
2007: Johannes F T Arnold; Markus Kotas; Florian Fidler; Eberhard D Pracht; Michael Flentje; Peter M Jakob
Quantitative regional oxygen transfer imaging of the human lung.
Journal of magnetic resonance imaging : JMRI 2007;26(3):637-45.
2007: Adrian Staab; Jürgen Löffler; Harun M Said; Astrid Katzer; Melanie Beyer; Buelent Polat; Hermann Einsele; Michael Flentje; Dirk Vordermark
Modulation of glucose metabolism inhibits hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha).
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(7):366-73.
2007: Matthias Guckenberger; Juergen Meyer; Juergen Wilbert; Kurt Baier; Klaus Bratengeier; Dirk Vordermark; Michael Flentje
Precision required for dose-escalated treatment of spinal metastases and implications for image-guided radiation therapy (IGRT).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;84(1):56-63.
2007: Harun M Said; Carsten Hagemann; Adrian Staab; Jelena Anacker; Siglinde Kühnel; Giles H Vince; Michael Flentje; Klaus Roosen; Dirk Vordermark
Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(3):398-405.
2007: Dirk Vordermark; Dorothee Marold; Susanne Wirth; Ludwig Keilholz; Klaus Pfändner; Thomas Schimpke; Hans-Joachim Thiel; Jochen Willner; Klaus Ziegler; Matthias Guckenberger; Michael Flentje
Patterns of care in the radiotherapy of prostate cancer in Northern Bavaria 1998-2000.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(6):314-20.
2007: Matthias Guckenberger; Juergen Meyer; Juergen Wilbert; Kurt Baier; Otto Sauer; Michael Flentje
Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and limitations in clinical practice.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(6):307-13.
2007: Matthias Guckenberger; Juergen Wilbert; Juergen Meyer; Kurt Baier; Anne Richter; Michael Flentje
Is a single respiratory correlated 4D-CT study sufficient for evaluation of breathing motion?
International journal of radiation oncology, biology, physics 2007;67(5):1352-9.
2007: Matthias Guckenberger; Juergen Meyer; Juergen Wilbert; Anne Richter; Kurt Baier; Gerd Mueller; Michael Flentje
Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(1):57-64.
2007: Jürgen Meyer; Juergen Wilbert; Kurt Baier; Matthias Guckenberger; Anne Richter; Otto Sauer; Michael Flentje
Positioning accuracy of cone-beam computed tomography in combination with a HexaPOD robot treatment table.
International journal of radiation oncology, biology, physics 2007;67(4):1220-8.
2007: Matthias Guckenberger; Michael Flentje
Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(2):57-62.
2007: Matthias Guckenberger; Michael Flentje
Intensity-modulated radiotherapy for the treatment of pelvic lymph nodes in prostate cancer.
Future oncology (London, England) 2007;3(1):43-7.
2007: Adrian Staab; Jürgen Loeffler; Harun M Said; Désirée Diehlmann; Astrid Katzer; Melanie Beyer; Markus Fleischer; Franz Schwab; Kurt Baier; Hermann Einsele; Michael Flentje; Dirk Vordermark
Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells.
BMC cancer 2007;7():213.
2007: Harun M Said; Carsten Hagemann; Jelena Anacker; Beate Schoemig; Giles H Vince; Michael Flentje; Klaus Roosen; Dirk Vordermark
GAPDH is not regulated in human glioblastoma under hypoxic conditions.
BMC molecular biology 2007;8():55.
2007: Claus Rödel; Torsten Liersch; Robert Michael Hermann; Dirk Arnold; Thomas Reese; Matthias Hipp; Alois Fürst; Nimrod Schwella; Michael Bieker; Gunter Hellmich; Hermann Ewald; Jörg Haier; Florian Lordick; Michael Flentje; Heiko Sülberg; Werner Hohenberger; Rolf Sauer
Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):110-7.
2007: Harun M Said; Adrian Staab; Carsten Hagemann; Giles H Vince; Astrid Katzer; Michael Flentje; Dirk Vordermark
Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.
Journal of neuro-oncology 2007;81(1):27-38.
2006: Matthias Guckenberger; Fabian Pohl; Kurt Baier; Juergen Meyer; Oliver Koelbl; Michael Flentje; Dirk Vordermark
Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2006;182(12):721-6.
2006: Eberhard D Pracht; André Fischer; Johannes F T Arnold; Markus Kotas; Michael Flentje; Peter M Jakob
Single-shot quantitative perfusion imaging of the human lung.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2006;56(6):1347-51.
2006: Hermann L Müller; Ursel Gebhardt; F Pohl; Michael Flentje; Angela Emser; Monika Warmuth-Metz; Reinhard Kolb; Gabriele Calaminus; Niels Sörensen
Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma.
Klinische Pädiatrie 2006;218(6):315-20.
2006: Martin Fassnacht; Stefanie Hahner; Buelent Polat; Ann-Cathrin Koschker; Werner Kenn; Michael Flentje; Bruno Allolio
Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.
The Journal of clinical endocrinology and metabolism 2006;91(11):4501-4.
2006: Rudolf M Huber; Michael Flentje; Michael Schmidt; Barbara Pöllinger; Helga Gosse; Jochen Willner; Kurt Ulm
Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(27):4397-404.
2006: Thomas Blankenburg; Michael Flentje; Godehard Friedel; Rudolf M Huber; Hans Tesch
[Concept of quality assurance in the management of lung carcinoma].
Onkologie 2006;29 Suppl 2():20-4.
2006: Matthias Guckenberger; Juergen Meyer; Dirk Vordermark; Kurt Baier; Juergen Wilbert; Michael Flentje
Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study.
International journal of radiation oncology, biology, physics 2006;65(3):934-42.
2006: Juergen Meyer; Anne Richter; Kurt Baier; Juergen Wilbert; Matthias Guckenberger; Michael Flentje
Tracking moving objects with megavoltage portal imaging: a feasibility study.
Medical physics 2006;33(5):1275-80.
2006: Susann Bürger; Detlev Schindler; Martin Fehn; Bettina Mühl; Hartmut Mahrhofer; Michael Flentje; Holger Hoehn; Eva Seemanová; Cholpon S Djuzenova
Radiation-induced DNA damage and repair in peripheral blood mononuclear cells from Nijmegen breakage syndrome patients and carriers assessed by the Comet assay.
Environmental and molecular mutagenesis 2006;47(4):260-70.
2006: Cholpon S Djuzenova; Bettina Mühl; M Fehn; Ulrich Oppitz; B Müller; Michael Flentje
Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays.
British journal of cancer 2006;94(8):1194-203.
2006: Gabriele Beckmann; Rainer Fietkau; Rudolf M Huber; Philip Kleine; Michael Schmidt; Sabine Semrau; Delphine Aubert; Alberto Fittipaldo; Michael Flentje
Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study.
Onkologie 2006;29(4):137-42.
2006: Matthias Guckenberger; Fabian Pohl; Kurt Baier; Juergen Meyer; Dirk Vordermark; Michael Flentje
Adverse effect of a distended rectum in intensity-modulated radiotherapy (IMRT) treatment planning of prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;79(1):59-64.
2006: Robert Semrau; Rolf-Peter Mueller; Hartmut Stuetzer; Susanne Staar; Ursula Schroeder; Orlando Guntinas-Lichius; Martin Kocher; Hans Theodor Eich; Andreas Dietz; Michael Flentje; Volker Rudat; Peter Volling; Michael Schroeder; Hans Edmund Eckel
Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.
International journal of radiation oncology, biology, physics 2006;64(5):1308-16.
2006: Matthias Guckenberger; Michael Flentje
Late small bowel toxicity after adjuvant treatment for rectal cancer.
International journal of colorectal disease 2006;21(3):209-20.
2006: Hartmut Mahrhofer; Susann Bürger; Ulrich Oppitz; Michael Flentje; Cholpon S Djuzenova
Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assessed by histone H2AX phosphorylation.
International journal of radiation oncology, biology, physics 2006;64(2):573-80.
2006: Dirk Vordermark; Klemens Ruprecht; Peter Rieckmann; Wolfgang Roggendorf; Giles H Vince; Monika Warmuth-Metz; Oliver Kölbl; Michael Flentje
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
BMC cancer 2006;6():247.
2006: Jürgen Meyer; Kurt Baier; Juergen Wilbert; Matthias Guckenberger; Anne Richter; Michael Flentje
Three-dimensional spatial modelling of the correlation between abdominal motion and lung tumour motion with breathing.
Acta oncologica (Stockholm, Sweden) 2006;45(7):923-34.
2006: Matthias Guckenberger; Juergen Meyer; Juergen Wilbert; Kurt Baier; Gerd Mueller; Jörn Wulf; Michael Flentje
Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors.
Acta oncologica (Stockholm, Sweden) 2006;45(7):897-906.
2006: Jörn Wulf; Matthias Guckenberger; Ulrich Haedinger; Ulrich Oppitz; Gerd Mueller; Kurt Baier; Michael Flentje
Stereotactic radiotherapy of primary liver cancer and hepatic metastases.
Acta oncologica (Stockholm, Sweden) 2006;45(7):838-47.
2006: Matthias Guckenberger; Jürgen Meyer; Kurt Baier; Dirk Vordermark; Michael Flentje
Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
Radiation oncology (London, England) 2006;1():34.
2006: Dirk Vordermark; Jörn Wulf; Klaus Markert; Kurt Baier; Oliver Kölbl; Gabriele Beckmann; Klaus Bratengeier; Michael Noe; Georg Schön; Michael Flentje
3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: a cross-sectional quality-of-life survey.
Acta oncologica (Stockholm, Sweden) 2006;45(6):708-16.
2006: Dirk Vordermark; Harun M Said; Astrid Katzer; Thomas Kuhnt; Gabriele Hänsgen; Jürgen Dunst; Michael Flentje; Matthias Bache
Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system.
BMC cancer 2006;6():207.
2006: Dirk Vordermark; Ines Seufert; Franz Schwab; Oliver Kölbl; Margret Kung; Christiane E Angermann; Michael Flentje
3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
Radiation oncology (London, England) 2006;1():10.
2006: Peter Schmitt; Mark Griswold; Vikas Gulani; Axel Haase; Michael Flentje; Peter M Jakob
A simple geometrical description of the TrueFISP ideal transient and steady-state signal.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2006;55(1):177-86.
2005: Dirk Vordermark; Peter Kraft; Astrid Katzer; Tobias Bölling; Jochen Willner; Michael Flentje
Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha).
Cancer letters 2005;230(1):122-33.
2005: Jörn Wulf; Kurt Baier; Gerd Mueller; Michael Flentje
Dose-response in stereotactic irradiation of lung tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;77(1):83-7.
2005: Fabian Pohl; Julia Seufert; Annette Tauscher; Harald Lehmann; Hans-Werner Springorum; Michael Flentje; Oliver Koelbl
The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2005;181(8):529-33.
2005: Harun M Said; Astrid Katzer; Michael Flentje; Dirk Vordermark
Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;76(2):200-5.
2005: Dirk Vordermark; Ines Seufert; Franz Schwab; Michael Flentje; Margret Kung; Christiane E Angermann
Cardiac toxicity of mediastinal radiotherapy: which are the critical structures?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3634-6; author reply 3636.
2005: Dirk Vordermark; Anja Kaffer; Susanne Riedl; Astrid Katzer; Michael Flentje
Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells.
International journal of radiation oncology, biology, physics 2005;61(4):1197-207.
2005: Oliver Koelbl; Franz Schwab; Klaus Bratengeier; Dirk Vordermark; Michael Flentje
Radiotherapy of prostate cancer with multileaf collimators (MLCs) optimization of the undulating dose distribution at the MLC edge.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2005;181(2):108-12.
2005: Dirk Vordermark; Oliver Kölbl; Klemens Ruprecht; Giles H Vince; Klaus Bratengeier; Michael Flentje
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
BMC cancer 2005;5():55.
2005: Ulrich Haedinger; Thomas Krieger; Michael Flentje; Jörn Wulf
Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets.
International journal of radiation oncology, biology, physics 2005;61(1):239-49.
2005: Gabriele Beckmann; Florian Hoppe; Leo Pfreundner; Michael Flentje
Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer.
Head & neck 2005;27(1):36-43.
2004: Cholpon S Djuzenova; Michael Flentje; Pierce Nicholas Plowman
Radiation response in vitro of fibroblasts from a fanconi anemia patient with marked clinical radiosensitivity.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2004;180(12):789-97.
2004: Oliver Koelbl; Thomas Krieger; Ulrich Haedinger; Otto Sauer; Michael Flentje
Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2004;180(12):783-8.
2004: Daniel Zips; Markus Adam; Michael Flentje; Axel Haase; Michael Molls; Wolfgang Mueller-Klieser; Cordula Petersen; Christine Philbrook; Peter Schmitt; Oliver Thews; Stefan Walenta; Michael Baumann
Impact of hypoxia and the metabolic microenvironment on radiotherapy of solid tumors. Introduction of a multi-institutional research project.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2004;180(10):609-15.
2004: Jörn Wulf; Ulrich Haedinger; Ulrich Oppitz; Wibke Thiele; Gerd Mueller; Michael Flentje
Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients.
International journal of radiation oncology, biology, physics 2004;60(1):186-96.
2004: Jochen Willner; Viktor Wiens; Manfred Jachmann; Imme Haubitz; Michael Flentje
Is survival following post-operative radiotherapy in pN1-non-small cell lung cancer reduced? Results of a multivariate analysis.
Oncology reports 2004;12(3):647-53.
2004: Gabriele Beckmann; Oliver Kölbl; Thomas Krieger; Jörn Wulf; Michael Flentje
How can we further improve radiotherapy for stage-III non-small-cell lung cancer?
Lung cancer (Amsterdam, Netherlands) 2004;45 Suppl 2():S125-32.
2004: Cholpon S Djuzenova; Bettina Mühl; R Schakowski; Ulrich Oppitz; Michael Flentje
Normal expression of DNA repair proteins, hMre11, Rad50 and Rad51 but protracted formation of Rad50 containing foci in X-irradiated skin fibroblasts from radiosensitive cancer patients.
British journal of cancer 2004;90(12):2356-63.
2004: Harald Reinhard; O Semler; Dietrich Bürger; Udo Bode; Michael Flentje; U Göbel; Peter Gutjahr; Ivo Leuschner; E Maass; Felix K Niggli; Hans G Scheel-Walter; Michael Stöckle; Joachim W Thüroff; Jochen Tröger; Angela Weirich; Dietrich von Schweinitz; Andreas Zoubek; Norbert Graf
Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Klinische Pädiatrie 2004;216(3):132-40.
2004: Peter Schmitt; Mark Griswold; Peter M Jakob; Markus Kotas; Vikas Gulani; Michael Flentje; Axel Haase
Inversion recovery TrueFISP: quantification of T(1), T(2), and spin density.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2004;51(4):661-7.
2004: Jörn Wulf; Karoline Popp; Ulrich Oppitz; Kurt Baier; Michael Flentje
Positional variability of a tandem applicator system in HDR brachytherapy for primary treatment of cervix cancer. Analysis of the anatomic pelvic position and comparison of the applicator positions during five insertions.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2004;180(4):216-24.
2004: Dirk Vordermark; Astrid Katzer; Kurt Baier; Peter Kraft; Michael Flentje
Cell type-specific association of hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein accumulation and radiobiologic tumor hypoxia.
International journal of radiation oncology, biology, physics 2004;58(4):1242-50.
2004: Jamshid Farahati; Markus Geling; Uwe Mäder; Markus Mörtl; Markus Luster; Justus G Müller; Michael Flentje; Christoph Reiners
Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995.
Thyroid : official journal of the American Thyroid Association 2004;14(2):141-7.
2004: Stefan Höcht; Riad Hammad; H Thiel; Thomas Wiegel; Alessandra Siegmann; J Willner; Peter Wust; Thomas Herrmann; Michael J Eble; D Carstens; Michael Flentje; P Neumann; Wolfgang Hinkelbein
A multicenter analysis of 123 patients with recurrent rectal cancer within the pelvis.
Frontiers of radiation therapy and oncology 2004;38():41-51.
2004: Klaus Bratengeier; Walter Baur; Kurt Baier; Jörn Wulf; Michael Flentje
A table top suited for CT and radiotherapy.
Zeitschrift für medizinische Physik 2004;14(2):118-22.
2004: Jörn Wulf; Ulrich Hädinger; Ulrich Oppitz; Wibke Thiele; Michael Flentje
Stereotactic boost irradiation for targets in the abdomen and pelvis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;70(1):31-6.
2004: Stefan Höcht; Riad Hammad; Hans-Joachim Thiel; Thomas Wiegel; Alessandra Siegmann; Jochen Willner; Peter Wust; Thomas Herrmann; Michael J Eble; Michael Flentje; Detlef Carstens; Dirk Bottke; Patrick Neumann; Wolfgang Hinkelbein
Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2004;180(1):15-20.
2004: Jörn Wulf; Karin Krämer; Claas van Aaken; Franz Dietzel; Dietrich Lucas; Klaus Pfändner; Thomas Schimpke; Wolfgang Schulze; Hans-Joachim Thiel; Klaus Ziegler; Michael Flentje
Outcome of postoperative treatment for rectal cancer UICC stage II and III in day-to-day clinical practice. Results from a retrospective quality control analysis in six institutions in North Bavaria (Germany).
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2004;180(1):5-14.
2003: Dirk Vordermark; Michael Schwab; Rhea Ness-Dourdoumas; Marco Sailer; Michael Flentje; Oliver Koelbl
Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;69(2):209-14.
2003: Oliver Koelbl; Julia Seufert; Fabian Pohl; Annette Tauscher; Harald Lehmann; Hans-Werner Springorum; Michael Flentje
Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(11):767-73.
2003: Jochen Willner; Andre Jost; Kurt Baier; Michael Flentje
A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(8):548-56.
2003: Leo Pfreundner; Florian Hoppe; Jochen Willner; Verena Preisler; Klaus Bratengeier; Rudolf Hagen; Jan Helms; Michael Flentje
Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ preservation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;68(2):163-70.
2003: Oliver Koelbl; Dirk Vordermark; Michael Flentje
The relationship between belly board position and patient anatomy and its influence on dose-volume histogram of small bowel for postoperative radiotherapy of rectal cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;67(3):345-9.
2003: Gabriele Beckmann; Michael Flentje
[Present status of treatment in nasopharyngeal carcinoma?].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(5):283-91.
2003: Hermann Faller; Barbara Olshausen; Michael Flentje
[Emotional distress and needs for psychosocial support among breast cancer patients at start of radiotherapy].
Psychotherapie, Psychosomatik, medizinische Psychologie 2003;53(5):229-35.
2003: Peter Schmitt; Markus Kotas; Anja Tobermann; Axel Haase; Michael Flentje
Quantitative tissue perfusion measurements in head and neck carcinoma patients before and during radiation therapy with a non-invasive MR imaging spin-labeling technique.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;67(1):27-34.
2003: Fabian Pohl; Sylke Hassel; Anja Nohe; Michael Flentje; Petra Knaus; Walter Sebald; Oliver Koelbl
Radiation-induced suppression of the Bmp2 signal transduction pathway in the pluripotent mesenchymal cell line C2C12: an in vitro model for prevention of heterotopic ossification by radiotherapy.
Radiation research 2003;159(3):345-50.
2003: Jochen Willner; Dirk Vordermark; Michael Schmidt; Andreamaria Gassel; Michael Flentje; Hubert Wirtz
Secretory activity and cell cycle alteration of alveolar type II cells in the early and late phase after irradiation.
International journal of radiation oncology, biology, physics 2003;55(3):617-25.
2003: Jörn Wulf; Ulrich Hädinger; Ulrich Oppitz; Wibke Thiele; Michael Flentje
Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;66(2):141-50.
2002: Cholpon S Djuzenova; Michael Flentje
Characterization of Fanconi anemia fibroblasts in terms of clonogenic survival and DNA damage assessed by the Comet assay.
Medical science monitor : international medical journal of experimental and clinical research 2002;8(10):BR421-30.
2002: Ulrich Oppitz; S Schulte; Helga Stopper; Kurt Baier; M Müller; Jörn Wulf; R Schakowski; Michael Flentje
In vitro radiosensitivity measured in lymphocytes and fibroblasts by colony formation and comet assay: comparison with clinical acute reactions to radiotherapy in breast cancer patients.
International journal of radiation biology 2002;78(7):611-6.
2002: Dirk Vordermark; Michael Schwab; Michael Flentje; Marco Sailer; Oliver Kölbl
Chronic fatigue after radiotherapy for carcinoma of the prostate: correlation with anorectal and genitourinary function.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002;62(3):293-7.
2002: Jochen Willner; Kurt Baier; Ekaterini Caragiani; Alexander Tschammler; Michael Flentje
Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2002;52(2):382-9.
2002: Dirk Vordermark; Marco Sailer; Michael Flentje; Arnulf Thiede; Oliver Kölbl
Impaired sphincter function and good quality of life in anal carcinoma patients after radiotherapy: a paradox?
Frontiers of radiation therapy and oncology 2002;37():132-9.
2001: Jörn Wulf; Ulrich Hädinger; Ulrich Oppitz; Wibke Thiele; R Ness-Dourdoumas; Michael Flentje
Stereotactic radiotherapy of targets in the lung and liver.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2001;177(12):645-55.
2001: Markus Kotas; Jochen Willner; Michael Flentje
Sequential chemo-radiotherapy in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;33 Suppl 1():S61-4.
2001: Cholpon S Djuzenova; Michael Flentje
Light scatter and DNA accessibility to propidium iodide of ataxia telangiectasia and fanconi anemia cells.
Biochemical and biophysical research communications 2001;286(2):365-71.
2001: Oliver Koelbl; Petra Knaus; Fabian Pohl; Michael Flentje; Walter Sebald
Radiation-induced reduction of BMP-induced proteoglycan synthesis in an embryonal mesenchymal tissue equivalent using the chicken "limb bud" test.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2001;177(8):432-6.
2001: Jochen Willner; Michael Flentje; W Lieb
Soft X-ray therapy of recurrent pterygium--an alternative to 90Sr eye applicators.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2001;177(8):404-9.
2001: Susanne Staar; Volker Rudat; Hartmut Stuetzer; Andreas Dietz; Peter Volling; M Schroeder; Michael Flentje; Hans Edmund Eckel; Rolf-Peter Mueller
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
International journal of radiation oncology, biology, physics 2001;50(5):1161-71.
2001: Dirk Vordermark; Michael Flentje; Marco Sailer; Oliver Kölbl
Intracavitary afterloading boost in anal canal carcinoma. Results, function and quality of life.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2001;177(5):252-8.
2001: Jochen Willner; Michael Schmidt; J Kirschner; S Lang; A Borgmeier; R M Huber; Michael Flentje
Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer. Results of a dose escalation study.
Lung cancer (Amsterdam, Netherlands) 2001;32(2):163-71.
2001: Cholpon S Djuzenova; A Rothfuss; Ulrich Oppitz; G Spelt; Detlev Schindler; Holger Hoehn; Michael Flentje
Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay.
Laboratory investigation; a journal of technical methods and pathology 2001;81(2):185-92.
2001: Ulrich Oppitz; Kurt Baier; Jörn Wulf; R Schakowski; Michael Flentje
The in vitro colony assay: a predictor of clinical outcome.
International journal of radiation biology 2001;77(1):105-10.
2001: Oliver Koelbl; A Rosenwald; M Haberl; J Müller; Jürgen Reuther; Michael Flentje
p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? an immunohistochemical and clinicopathologic study.
International journal of radiation oncology, biology, physics 2001;49(1):147-54.
2000: Dirk Vordermark; Oliver Kölbl; Michael Flentje
The Internet as a source of medical information. Investigation in a mixed cohort of radiotherapy patients.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(11):532-5.
2000: Jörn Wulf; Ulrich Hädinger; Ulrich Oppitz; B Olshausen; Michael Flentje
Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;57(2):225-36.
2000: Klaus Bratengeier; Leo Pfreundner; Michael Flentje
Radiation techniques for head and neck tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;56(2):209-20.
2000: Leo Pfreundner; Jochen Willner; A Marx; Florian Hoppe; Gabriele Beckmann; Michael Flentje
The influence of the radicality of resection and dose of postoperative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract.
International journal of radiation oncology, biology, physics 2000;47(5):1287-97.
2000: A Hermann; Klaus Bratengeier; A Priske; Michael Flentje
A new verification film system for routine quality control of radiation fields: Kodak EC-L.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(6):274-7.
2000: Dirk Vordermark; Georg Becker; Michael Flentje; S Richter; I Goerttler-Krauspe; Oliver Koelbl
Transcranial sonography: integration into target volume definition for glioblastoma multiforme.
International journal of radiation oncology, biology, physics 2000;47(3):565-71.
2000: A Bagatzounis; Jochen Willner; Ulrich Oppitz; Michael Flentje
The postoperative adjuvant radiation therapy and radiochemotherapy for UICC stage II and III rectal cancer. A retrospective analysis.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(3):112-7.
2000: Oliver Kölbl; S Richter; Michael Flentje
Influence of treatment technique on dose-volume histogram and normal tissue complication probability for small bowel and bladder. A prospective study using a 3-D planning system and a radiobiological model in patients receiving postoperative pelvic irradiation.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(3):105-11.
2000: Rolf-Dieter Kortmann; Joachim Kühl; Beate Timmermann; Uwe Mittler; Christian Urban; V Budach; E Richter; Normann Willich; Michael Flentje; F Berthold; I Slavc; J Wolff; Christoph Meisner; O Wiestler; Niels Sörensen; Monika Warmuth-Metz; D D
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
International journal of radiation oncology, biology, physics 2000;46(2):269-79.
2000: Jörn Wulf; Michael Flentje
[Results of radiotherapy in rectal carcinoma].
Zentralblatt für Chirurgie 2000;125 Suppl 1():28-32.
2000: Jan Helms; Konrad Schwager; Florian Hoppe; Jan Pahnke; V Preissler; Michael Flentje; Leo Pfreundner; J Richter; W Bohndorf
Interdisciplinary cooperative oncology for special head and neck malignancies.
Otolaryngologia polska. The Polish otolaryngology 2000;54(3):241-3.
2000: Dietmar Zierhut; Frank Lohr; P Schraube; Peter Huber; Frederik Wenz; Rainer Haas; D Fehrentz; Michael Flentje; W Hunstein; Michael Wannenmacher
Cataract incidence after total-body irradiation.
International journal of radiation oncology, biology, physics 2000;46(1):131-5.
1999: Volker Rudat; Andreas Dietz; Jörg Nollert; Christian Conradt; Klaus-Josef Weber; Michael Flentje; Michael Wannenmacher
Acute and late toxicity, tumour control and intrinsic radiosensitivity of primary fibroblasts in vitro of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;53(3):233-45.
1999: Oliver Koelbl; S Richter; Michael Flentje
Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model.
International journal of radiation oncology, biology, physics 1999;45(5):1193-8.
1999: Volker Rudat; Andreas Dietz; Oana G Schramm; Christian Conradt; Heinz Maier; Michael Flentje; Michael Wannenmacher
Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;53(2):119-25.
1999: Ulrich Oppitz; D Maessen; H Zunterer; S Richter; Michael Flentje
3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;53(1):53-7.
1999: Jochen Willner; Michael Flentje
[Combined radiochemotherapy of non-small-cell bronchial carcinoma with taxol].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1999;175 Suppl 3():14-9.
1999: Dirk Vordermark; Marco Sailer; Michael Flentje; Arnulf Thiede; Oliver Kölbl
Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;52(3):239-43.
1999: Jochen Willner; IC Kiricuta; Oliver Kölbl; Michael Flentje
Long-term survival following postmastectomy locoregional recurrence of breast cancer.
Breast (Edinburgh, Scotland) 1999;8(4):200-4.
1999: Ulrich Oppitz; U Bernthaler; Detlev Schindler; Alexandra Sobeck; Holger Hoehn; Matthias Platzer; A Rosenthal; Michael Flentje
Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects.
International journal of radiation oncology, biology, physics 1999;44(5):981-8.
1999: Ulrich Oppitz; S Denzinger; U Nachtrab; Michael Flentje; Helga Stopper
Radiation-induced comet-formation in human skin fibroblasts from radiotherapy patients with different normal tissue reactions.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1999;175(7):341-6.
1999: Leo Pfreundner; Konrad Schwager; Jochen Willner; Kurt Baier; Klaus Bratengeier; FX Brunner; Michael Flentje
Carcinoma of the external auditory canal and middle ear.
International journal of radiation oncology, biology, physics 1999;44(4):777-88.
1999: M Kolb; Jochen Willner; E Köberlein; U Hoffmann; J Kirschner; Michael Flentje; Michael Schmidt
[Autocrine activation of fibroblasts following irradiation].
Pneumologie (Stuttgart, Germany) 1999;53(6):296-301.
1999: Cholpon S Djuzenova; Detlev Schindler; Helga Stopper; Holger Hoehn; Michael Flentje; Ulrich Oppitz
Identification of ataxia telangiectasia heterozygotes, a cancer-prone population, using the single-cell gel electrophoresis (Comet) assay.
Laboratory investigation; a journal of technical methods and pathology 1999;79(6):699-705.
1999: Jochen Willner; Kurt Baier; Leo Pfreundner; Michael Flentje
Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma.
Acta oncologica (Stockholm, Sweden) 1999;38(8):1025-30.
1998: Oliver Kölbl; D Knelles; Thomas Barthel; F Raunecker; Michael Flentje; Jochen Eulert
Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial.
International journal of radiation oncology, biology, physics 1998;42(2):397-401.
1998: Frank Lohr; Frederik Wenz; P Schraube; Michael Flentje; Rainer Haas; Dietmar Zierhut; D Fehrentz; W Hunstein; Michael Wannenmacher
Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for hematological malignancies.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;48(1):45-51.
1998: D Maessen; Michael Flentje; U Weischedel
[Cosmetic results of breast conserving therapy for breast carcinoma. Treatment results from the Heidelberg Radiation Clinic in the years 1984 to 1992].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1998;174(5):251-6.
1998: Detlev Latz; T Schulze; C Manegold; P Schraube; Michael Flentje; Klaus-Josef Weber
Combined effects of ionizing radiation and 4-hydroperoxyfosfamide in vitro.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;46(3):279-83.
1998: U Nachtrab; Ulrich Oppitz; Michael Flentje; Helga Stopper
Radiation-induced micronucleus formation in human skin fibroblasts of patients showing severe and normal tissue damage after radiotherapy.
International journal of radiation biology 1998;73(3):279-87.
1998: Leo Pfreundner; Kurt Baier; Franz Schwab; Jochen Willner; Klaus Bratengeier; Michael Flentje; H Feustel; K H Fuchs
[3D-Ct-planned interstitial HDR brachytherapy + percutaneous irradiation and chemotherapy in inoperable pancreatic carcinoma. Methods and clinical outcome].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1998;174(3):133-41.
1998: Michael Flentje; Angela Weirich; Norbert Graf; R Pötter; H Zimmerman; R Ludwig
Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival.
International journal of radiation oncology, biology, physics 1998;40(1):163-9.
1997: Oliver Kölbl; Michael Flentje; Jochen Eulert; Thomas Barthel; D Knelles; U Kraus
[Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1997;173(12):677-82.
1997: Oliver Kölbl; D Knelles; Thomas Barthel; U Kraus; Michael Flentje; Jochen Eulert
Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
International journal of radiation oncology, biology, physics 1997;39(5):961-6.
1997: Oliver Kölbl; Klaus Bratengeier; S Richter; R Henkel; R Schmidt; Michael Flentje
[Intracavitary afterloading therapy as a new technique of boost irradiation in anal canal carcinoma].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1997;173(10):513-8.
1997: Jochen Willner; Michael Flentje; Klaus Bratengeier
CT simulation in stereotactic brain radiotherapy--analysis of isocenter reproducibility with mask fixation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;45(1):83-8.
1997: Peter Fritz; Christiane Berns; HW Anton; Frank W Hensley; J Assman; Michael Flentje; Dietrich Von Fournier; Michael Wannenmacher
PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;45(1):23-32.
1997: Detlev Latz; P Schraube; U Oppitz; Christian Kugler; C Manegold; Michael Flentje; M F Wannenmacher
Invasive thymoma: treatment with postoperative radiation therapy.
Radiology 1997;204(3):859-64.
1997: Jochen Willner; Ulrich Hädinger; M Neumann; Franz Schwab; Klaus Bratengeier; Michael Flentje
Three dimensional variability in patient positioning using bite block immobilization in 3D-conformal radiation treatment for ENT-tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;43(3):315-21.
1997: Volker Rudat; Andreas Dietz; Christian Conradt; Klaus-Josef Weber; Michael Flentje
In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;43(2):181-8.
1997: PM Messer; I C Kirikuta; Klaus Bratengeier; Michael Flentje
CT planning of boost irradiation in radiotherapy of breast cancer after conservative surgery.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;42(3):239-43.
1997: Frederik Wenz; Frank Lohr; Michael Flentje; Volker Rudat; Andreas Dietz; Michael Wannenmacher
Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy.
International journal of radiation oncology, biology, physics 1997;37(4):771-6.
1997: Dietmar Zierhut; Michael Flentje; Gabriele Sroka-Perez; V Rudat; Rita Engenhart-Cabillic; Michael Wannenmacher
[The conformal radiotherapy of localized prostatic carcinoma: acute tolerance and early efficacy].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1997;173(2):98-105.
1997: A Bagatzounis; Oliver Kölbl; G Müller; Ulrich Oppitz; Jochen Willner; Michael Flentje
[The locoregional recurrence of rectal carcinoma. A computed tomographic analysis and a target volume concept for adjuvant radiotherapy].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1997;173(2):68-75.
1997: Oliver Kölbl; IC Kiricuta; Jochen Willner; Michael Flentje
[Bone metastasis in breast carcinoma].
Zentralblatt für Chirurgie 1997;122(2):97-102.
1996: Andreas Dietz; Volker Rudat; Jörg Nollert; Michael Flentje; H Maiei; Michael Wannenmacher; Hagen Weidauer
[Accelerated hyperfractionated simultaneous radiochemotherapy in advanced head-neck carcinomas in comparison: split course and concomitant boost concept].
Laryngo- rhino- otologie 1996;75(12):745-53.
1996: Detlev Latz; W C Dewey; Michael Flentje; Frank Lohr; Frederik Wenz; Klaus-Josef Weber
Migration patterns in pulsed-field electrophoresis of DNA restriction fragments from log-phase mammalian cells after irradiation and incubation for repair.
International journal of radiation biology 1996;70(6):637-46.
1996: Eva-B Bröcker; W Bohndorf; Eckhart Kämpgen; J Trcka; P Messer; W Tilgen; K Engenhart; Michael Flentje
Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: report on a pilot study.
Melanoma research 1996;6(5):399-401.
1996: G Müller; I C Kiricuta; J Stiess; Michael Flentje
[Radiochemotherapy of non-small-cell bronchial carcinoma. A report of experience].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1996;172(8):446-54.
1996: V Rudat; P Schraube; D Oetzel; Dietmar Zierhut; Michael Flentje; Michael Wannenmacher
Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer.
International journal of radiation oncology, biology, physics 1996;35(5):1027-34.
1996: Peter Fritz; Klaus-Josef Weber; C Frank; Michael Flentje
Differential effects of dose rate and superfractionation on survival and cell cycle of V79 cells from spheroid and monolayer culture.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;39(1):73-9.
1996: C Herskind; S Haas; Michael Flentje; Eric W Hahn
Growth-state-dependent radiation-induced expression of the proto-oncogene c-fos in NIH 3T3 cells.
Radiation research 1996;145(3):299-303.
1996: Rainer Haas; Marion Moos; R Möhle; Hartmut Döhner; B Witt; Hartmut Goldschmidt; S Murea; Michael Flentje; Michael Wannenmacher; W Hunstein
High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Bone marrow transplantation 1996;17(2):149-55.
1995: D Oetzel; P Schraube; Frank W Hensley; G Sroka-Pérez; M Menke; Michael Flentje
Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.
International journal of radiation oncology, biology, physics 1995;33(2):455-60.
1995: Dietmar Zierhut; Michael Flentje; J Adolph; J Erdmann; F Raue; Michael Wannenmacher
External radiotherapy of pituitary adenomas.
International journal of radiation oncology, biology, physics 1995;33(2):307-14.
1995: V Rudat; Michael Flentje; R Engenhart; M Metzger; Michael Wannenmacher
[The belly-board technic for the sparing of the small intestine. Studies on positioning accuracy taking into consideration conformational irradiation technics].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1995;171(8):437-43.
1995: Andreas Dietz; Jörg Nollert; Heinz Maier; Volker Rudat; Michael Flentje
[The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].
HNO 1995;43(7):403-13.
1995: Rainer Haas; Marion Moos; A Karcher; R Möhle; B Witt; Hartmut Goldschmidt; Michael Flentje; Michael Wannenmacher; W Hunstein
[Sequential high-dose therapy in patients with low-malignity non-Hodgkin's lymphoma].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1995;171(5):300-1.
1995: Frank Lohr; Frederik Wenz; S Haas; Michael Flentje
Comparison of proliferating cell nuclear antigen (PCNA) staining and BrdUrd-labelling index under different proliferative conditions in vitro by flow cytometry.
Cell proliferation 1995;28(2):93-104.
1994: V Rudat; Michael Flentje; D Oetzel; M Menke; Wolfgang Schlegel; Michael Wannenmacher
Influence of the positioning error on 3D conformal dose distributions during fractionated radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;33(1):56-63.
1994: Rainer Haas; Marion Moos; A Karcher; R Möhle; B Witt; Hartmut Goldschmidt; S Frühauf; Michael Flentje; Michael Wannenmacher; W Hunstein
Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1685-92.
1994: C Frank; Michael Flentje; Hartmut Goldschmidt; W Hunstein; Michael Wannenmacher
Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1994;170(7):383-90.
1994: Rainer Haas; R Möhle; S Frühauf; Hartmut Goldschmidt; B Witt; Michael Flentje; Michael Wannenmacher; W Hunstein
Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma.
Blood 1994;83(12):3787-94.
1994: Dietmar Zierhut; Michael Flentje; C Frank; D Oetzel; Michael Wannenmacher
Conservative treatment of breast cancer: modified irradiation technique for women with large breasts.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;31(3):256-61.
1994: Michael Flentje; Angela Weirich; R Pötter; R Ludwig
Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;31(3):222-8.
1994: Frederik Wenz; Frank Lohr; Michael Flentje
Flow cytometric measurement of proliferating cell nuclear antigen (PCNA) in solid tumors.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1994;170(4):235-42.
1994: Michael J Eble; Frank W Hensley; Michael Flentje; A Schlotz; Michael Wannenmacher
A modified computer-assisted colorimetric microtitre assay (MTT) to assess in vitro radiosensitivity of V79, CaSki, HeLa and WiDr cells.
International journal of radiation biology 1994;65(2):193-201.
1993: Michael Flentje; Frank W Hensley; G Gademann; M Menke; Michael Wannenmacher
Renal tolerance to nonhomogenous irradiation: comparison of observed effects to predictions of normal tissue complication probability from different biophysical models.
International journal of radiation oncology, biology, physics 1993;27(1):25-30.
1993: Frank Lohr; Frederik Wenz; Michael Flentje; Peter Peschke; Eric W Hahn
Measurement of the proliferative activity of three different sublines of the Dunning rat prostate tumor R3327.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1993;169(7):438-45.
1993: Michael Flentje; Dietmar Zierhut; P Schraube; Michael Wannenmacher
Integration of coronal magnetic resonance imaging (MRI) into radiation treatment planning of mediastinal tumors.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1993;169(6):351-7.
1993: Michael Flentje; B Asadpour; Detlev Latz; Klaus-Josef Weber
Sensitivity of neutral filter elution but not PFGE can be modified by non-dsb chromatin damage.
International journal of radiation biology 1993;63(6):715-24.
1993: C Frank; Klaus-Josef Weber; Peter Fritz; Michael Flentje
Increased dose-rate effect in V79-multicellular aggregates (spheroids). Relation to initial DNA lesions and repair.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;26(3):264-70.
1992: C Walz; Jörg R Schlehofer; Michael Flentje; Volker Rudat; Harald zur Hausen
Adeno-associated virus sensitizes HeLa cell tumors to gamma rays.
Journal of virology 1992;66(9):5651-7.
1992: Michael Flentje; Michael J Eble; U Haner; S Trinh; Michael Wannenmacher
Additive effects of cisplatin and radiation in human tumor cells under oxic conditions.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;24(1):60-3.
1991: Detlev Latz; Michael Flentje; Michael J Eble; A Hör; M Wannenmacher
[Effects of lonidamine alone or in combination with radiotherapy on survival and metabolism in human and rodent cell lines].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1991;167(12):716-22.
1991: Michael Flentje; Detlev Latz; U Haner; A Hör; S Trinh; M Wannenmacher
[Additive effects of carboplatin (CBDCA) and Co-60 gamma rays in human tumor cells in vitro].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1991;167(4):244-9.
1990: J Görich; S A Beyer-Enke; Michael Flentje; Ivan Zuna; I Vogt-Moykopf; Gerhard van Kaick
[The place of computed tomography in the diagnosis of recurrences in patients with bronchogenic carcinoma].
Der Radiologe 1990;30(10):472-6.
1990: J Görich; S A Beyer-Enke; Michael Flentje; Ivan Zuna; I Vogt-Moykopf; Gerhard van Kaick
Evaluation of recurrent bronchogenic carcinoma by computed tomography.
Clinical imaging 1990;14(2):131-7.
1989: Michael Flentje; J Görich; M Wannenmacher
[Brain metastases. Radiologic diagnosis and therapy].
Der Radiologe 1989;29(5):212-8.
1989: J Görich; S A Beyer-Enke; H Schmitteckert; Michael Flentje; Gerhard van Kaick
Pleural metastasis of malignant thymoma. A pitfall in the CT-diagnosis of pleural mesothelioma.
Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society 1989;13(2):169-70.
1989: Michael Flentje; U Weischedel; C Wieland
[The results of radiotherapy in advanced oral carcinomas. The effect of altered therapeutic strategies].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1989;165(1):11-7.
1989: Michael Flentje; J Görich; J Adolph; B Kimmig
[Computed tomographic diagnosis of diseases of the pituitary region].
Der Radiologe 1989;29(1):7-13.
1988: J Görich; Michael Flentje; Friedemann J Gückel; S A Beyer-Enke; Gerhard van Kaick
[Computed tomographic imaging of collateral pathways in stenoses of the large mediastinal veins].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1988;148(5):560-5.
1988: K Rieden; J Adolph; Michael Flentje; U Mende; U Lellig; K zum Winkel
[Indications for and value of computed tomography and conventional skeletal diagnosis in suspected bone metastases].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1988;148(5):505-15.
1988: Michael Flentje; U Mende; U Weischedel; C Wieland
[Results of radiotherapy in advanced oropharyngeal carcinomas. Primary and postoperative radiotherapy versus radiotherapy following polychemotherapy].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1988;164(2):68-72.
1987: Michael Flentje; B Kober; H Kohlmann; G Schneider; B Kimmig
[Results of radiation therapy in brain metastases with reference to computerized tomography].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1987;163(3):148-53.
1986: Michael Flentje; P Hohenberger; J Adolph; B Kober
[Intra-arterial dynamic computed tomography in characterizing liver metastases of colorectal cancer].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1986;145(3):263-7.
1986: B Kober; Michael Flentje; J Adolph; K Rieden; J Bieber; K zum Winkel
[Functional heterogeneity of liver metastases in 3-phase computerized tomograms].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1986;144(6):707-10.